BACE1 and Alzheimer disease: We provided the first evidence that astrocytic BACE1 regulates astrocytic Aβ clearance by promoting more beneficial astrocytes in the reactive state, and inhibition of astrocytic BACE1 might be a novel target for future AD therapies, which can contribute to the reduction of Aβ deposition.